The national economical impact of epilepsy is estimated at $9.6 billion per year in the United States.
Seizure cost-effectiveness of therapy
Migraine cost-effectiveness of therapy
Anhedonia cost-effectiveness of therapy
Alcohol withdrawal cost-effectiveness of therapy
Delirium cost-effectiveness of therapy
Hearing impairment cost-effectiveness of therapy
Encephalopathy cost-effectiveness of therapy
Seizure future or investigational therapies